Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis

Clinical trial NCT00030381 · TERMINATED

Trial details

NCT number: NCT00030381
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Systemic Amyloidosis

Start date: 2001-12-01
Primary completion: 2003-01-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.